J
James Slater
Researcher at New York University
Publications - 114
Citations - 10279
James Slater is an academic researcher from New York University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 41, co-authored 111 publications receiving 9367 citations. Previous affiliations of James Slater include Hannover Medical School & University of York.
Papers
More filters
Journal ArticleDOI
Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Js. Hochman,La. Sleeper,John G. Webb,Timothy A. Sanborn,Harvey D. White,JD Talley,Christopher E. Buller,Alice K. Jacobs,James Slater,Jacques Col,Sonja M. McKinlay,Thierry H. LeJemtel +11 more
TL;DR: In patients with cardiogenic shock, emergency revascularization did not significantly reduce overall mortality at 30 days, but after six months there was a significant survival benefit, and earlyRevascularization should be strongly considered for patients with acute myocardial infarction complicated by cardiogenesis.
Journal ArticleDOI
One-Year Survival Following Early Revascularization for Cardiogenic Shock
Judith S. Hochman,Lynn A. Sleeper,Harvey D. White,Vladimir Dzavik,S. Chiu Wong,Venu Menon,John G. Webb,Richard M. Steingart,Michael H. Picard,Mark Menegus,Jean L. Boland,Timothy A. Sanborn,Christopher E. Buller,Sharada Modur,Robert Forman,Patrice Desvigne-Nickens,Alice K. Jacobs,James Slater,Thierry H. LeJemtel +18 more
TL;DR: It is recommended that rapid transfer of patients with AMI complicated by CS, particularly those younger than 75 years, to medical centers capable of providing early angiography and revascularization procedures is recommended.
Journal ArticleDOI
Short and Long-Term Outcomes with Drug Eluting and Bare Metal Coronary Stents: A Mixed Treatment Comparison Analysis of 117 762 Patient-Years of Follow-up from Randomized Trials
Sripal Bangalore,Sunil Kumar,Mario Fusaro,Nicholas Amoroso,Michael J. Attubato,Frederick Feit,Deepak L. Bhatt,James Slater +7 more
TL;DR: DES are highly efficacious at reducing the risk of target-vessel revascularization without an increase in any safety outcomes, including stent thrombosis and EES was the safest stent.
Journal ArticleDOI
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
Rupert Fincke,Judith S. Hochman,April M. Lowe,Venu Menon,James Slater,John G. Webb,Thierry H. LeJemtel,Gad Cotter,Shock Investigators +8 more
TL;DR: Cardiac power is the strongest independent hemodynamic correlate of in-hospital mortality in patients with cardiogenic shock and increasing age and female gender are independently associated with lower cardiac power.
Journal ArticleDOI
Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease.
Harmony R. Reynolds,Monvadi B. Srichai,Sohah N. Iqbal,James Slater,G.B. John Mancini,Frederick Feit,Ivan Pena-Sing,Leon Axel,Michael J. Attubato,Leonid Yatskar,Rebecca T. Kalhorn,David A. Wood,Iryna Lobach,Judith S. Hochman +13 more
TL;DR: Plaque rupture and ulceration are common in women with myocardial infarction without angiographically demonstrable obstructive coronary artery disease, and LGE is common in this cohort of women, with an ischemic pattern of injury most evident.